Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:approves |
gptkb:2020
|
| gptkbp:clinical_trial |
Phase 1
|
| gptkbp:developed_by |
gptkb:Pfizer
gptkb:Bio_NTech |
| https://www.w3.org/2000/01/rdf-schema#label |
BNT162b1
|
| gptkbp:is_effective_against |
approximately 90%
|
| gptkbp:mechanism_of_action |
induces immune response
|
| gptkbp:regulatory_compliance |
Emergency Use Authorization
|
| gptkbp:route_of_administration |
intramuscular
|
| gptkbp:targets |
gptkb:COVID-19
|
| gptkbp:type |
gptkb:vaccine
|
| gptkbp:bfsParent |
gptkb:Bio_NTech
|
| gptkbp:bfsLayer |
5
|